Related Experiment Video
Updated: Jan 6, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Embracing study heterogeneity for finding genetic interactions in large-scale research consortia
Yulun Liu1, Jing Huang2, Ryan J Urbanowicz3
1Department of Population and Data Sciences, The University of Texas Southwestern Medical Center, Dallas, Texas.
Identifying genetic interactions in complex diseases is challenging. A new method, YETI2, uses distributed genome-wide association study (GWAS) data heterogeneity to find these interactions without sharing personal information.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Genetic interactions are crucial for complex disease heritability but difficult to identify due to small effect sizes and stringent multiple-testing corrections.
- Large-scale consortia facilitate genome-wide association study (GWAS) data sharing, but privacy concerns and data heterogeneity pose challenges.
- Heterogeneity in marginal effects across distributed GWAS databases can provide novel insights into genetic interactions.
Purpose of the Study:
- To develop a novel statistical method for detecting genetic interactions in large-scale consortia.
- To address challenges of data privacy and heterogeneity in distributed GWAS databases.
- To leverage marginal effect heterogeneity for prioritizing potential genetic interactions.
Main Methods:
- Developed a novel two-stage testing procedure named phylogenY-based effect-size tests for interactions using first 2 moments (YETI2).
- YETI2 utilizes a meta-analytic framework to analyze both pooled marginal effects and heterogeneity in marginal effects across sites.
- The method is designed for large consortia without requiring the sharing of personal genomic information.
Main Results:
- YETI2 effectively detects genetic interactions by considering both averaged and heterogeneous marginal effects across distributed GWAS databases.
- The method can prioritize potential genetic interactions by leveraging underlying heterogeneity.
- Simulation studies demonstrated the performance of YETI2, and it was applied to bladder cancer data from dbGaP.
Conclusions:
- YETI2 offers a powerful new approach for identifying genetic interactions in complex diseases within large consortia.
- The method overcomes limitations of conventional approaches by utilizing data heterogeneity without compromising privacy.
- YETI2 enhances the discovery of genetic interactions relevant to complex diseases like bladder cancer.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Behavioral Genetics and Its Designs
The primary methodologies used in behavior genetics include family studies, twin studies, and adoption studies, each providing unique...
Heritability
Epistasis Analysis
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Single Nucleotide Polymorphisms-SNPs

